ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
951 Calle Amanecer
San Clemente, California 92673-6212
Phone: 19493662183
www.icumed.com
https://www.investing.com/news/stock-market-news/earnings-call-icu-medical-inc-sees-steady-growth-in-q2-2024-93CH-3562263
ICU Medical (NASDAQ: ICUI ) just reported results for the second quarter of 2024. ICU Medical reported earnings per share of $1.56. This was above the analyst estimate for EPS of $1.00. The company reported revenue of $596.46 million. This was 7.72% better than the analyst estimate for revenue of $553.70 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .
No summary available.
SAN CLEMENTE, Calif. (AP) — SAN CLEMENTE, Calif. (AP) — ICU Medical Inc. (ICUI) on Wednesday reported a loss of $21.4 million in its second quarter.
SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2024.
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call.
ICU Medical announces Q2 2024 earnings release on Aug 7. Join the conference call at 4:30 PM ET to discuss results. Webcast available on icumed.com for live and replay access. Learn about the latest financial performance.
Smiths Group plc (GB:SMIN) has released an update. Smiths Group plc has successfully divested 1.2 million shares of ICU Medical Inc, garnering appr…
